These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29486013)

  • 1. Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts.
    Wallach JD; Ross JS
    JAMA; 2018 Feb; 319(8):776-778. PubMed ID: 29486013
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic peripheral neuropathic pain: is gabapentin effective?
    Hyatt JD; Daniel D; Tran QV; Millares M; Kubota DR
    Am Fam Physician; 2011 Sep; 84(5):480, 482; author reply 482. PubMed ID: 21888297
    [No Abstract]   [Full Text] [Related]  

  • 3. Gabapentin for Chronic Neuropathic Pain.
    Garcia D
    Am Fam Physician; 2015 Dec; 92(11):Online. PubMed ID: 26760423
    [No Abstract]   [Full Text] [Related]  

  • 4. Apparent discrepancy between published study of gabapentin treatment and internal company report.
    Mayo-Wilson E
    J Clin Psychiatry; 2013 Aug; 74(8):853-4. PubMed ID: 24021509
    [No Abstract]   [Full Text] [Related]  

  • 5. Reporting of trials of gabapentin.
    Gordh TE; Jensen TS; Kalso E
    N Engl J Med; 2010 Apr; 362(17):1641; author reply 1641-2. PubMed ID: 20427815
    [No Abstract]   [Full Text] [Related]  

  • 6. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
    Goodman CW; Brett AS
    N Engl J Med; 2017 Aug; 377(5):411-414. PubMed ID: 28767350
    [No Abstract]   [Full Text] [Related]  

  • 7. Confounding factors in off-label drug use.
    Greenberg PE; Pike C; Sisitsky T
    Health Aff (Millwood); 2012 Feb; 31(2):460; author reply 460. PubMed ID: 22323178
    [No Abstract]   [Full Text] [Related]  

  • 8. Gabapentin for Chronic Neuropathic Pain.
    Moore A; Derry S; Wiffen P
    JAMA; 2018 Feb; 319(8):818-819. PubMed ID: 29486015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False Claims Act prosecution did not deter off-label drug use in the case of neurontin.
    Kesselheim AS; Darby D; Studdert DM; Glynn R; Levin R; Avorn J
    Health Aff (Millwood); 2011 Dec; 30(12):2318-27. PubMed ID: 22147859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.
    Chace MJ; Zhang F; Fullerton CA; Huskamp HA; Gilden D; Soumerai SB
    J Clin Psychiatry; 2012 Nov; 73(11):1388-94. PubMed ID: 23146199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromising the medical literature: the hidden influence of industry-biased articles.
    Fugh-Berman A; Siwek J
    Am Fam Physician; 2011 Sep; 84(5):489-90. PubMed ID: 21888299
    [No Abstract]   [Full Text] [Related]  

  • 12. Dr. Vieta replies.
    Vieta E
    J Clin Psychiatry; 2013 Aug; 74(8):854. PubMed ID: 24021510
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome reporting in industry-sponsored trials of gabapentin for off-label use.
    Vedula SS; Bero L; Scherer RW; Dickersin K
    N Engl J Med; 2009 Nov; 361(20):1963-71. PubMed ID: 19907043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence, regulation and 'rational' prescribing: the case of gabapentin for neuropathic pain.
    Ghinea N; Lipworth W; Kerridge I
    J Eval Clin Pract; 2015 Feb; 21(1):28-33. PubMed ID: 24986307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pfizer versus Kaiser: insurers want their day in court.
    Silverman E
    BMJ; 2013 Jun; 346():f3738. PubMed ID: 23760967
    [No Abstract]   [Full Text] [Related]  

  • 16. Off-label gabapentin masking ictal triphasic waves: case analysis of neuropsychiatric and electrographic correlates.
    Kaufman KR; Struck PJ; Wu B; Wong S
    Epilepsy Behav; 2011 Nov; 22(3):606-9. PubMed ID: 21945412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin toxicity in renal failure: the importance of dose adjustment.
    Miller A; Price G
    Pain Med; 2009 Jan; 10(1):190-2. PubMed ID: 18721173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label prescribing explained. Why your doctor may recommend meds that aren't FDA-approved for your condition.
    Johns Hopkins Med Lett Health After 50; 2011 Jun; 23(4):7. PubMed ID: 21702115
    [No Abstract]   [Full Text] [Related]  

  • 19. Suicide by gabapentin overdose.
    Middleton O
    J Forensic Sci; 2011 Sep; 56(5):1373-5. PubMed ID: 21554310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin-induced sexual dysfunction.
    Kaufman KR; Struck PJ
    Epilepsy Behav; 2011 Jul; 21(3):324-6. PubMed ID: 21612983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.